Şunu aradınız:: crcl (İngilizce - Danca)

crcl(ml/min)
crcl (ml/min)

crcl≤ 10 ml/ min.
initialdosis mg/ dag 5- 10 mg 2, 5 mg

elderly normal crcl:
normal crcl:

estimated crcl (ml/min)
estimeret crcl (ml/min)

crcl < 50 ml/minut e
behandlingen hvis crcl < 50 ml/minut

glomerular filtration rate (crcl,)
glomerulær filtrationshastighed (crcl)

crcl <70 ml/min (n=214)
crcl < 70 ml/min (n=214)

discontinue ribavirin if crcl < 50ml/min
seponer ribavirin- behandlingen hvis crcl < 50 ml/min

renal function (crcl in ml/min)
nyrefunktion (crcl i ml/min)

1 crcl estimated using the cockcroft-gault formula
1 crcl estimeret ved anvendelse af cockcroft-gault-formlen

mild renal impairment (crcl 51 to 80 ml/min)
let nedsat nyrefunktion (crcl 51-80 ml/min.)

a calculated using the schwartz formula b dose is based on crcl.
a beregnet under anvendelse af schwartz-formlen b dosen er baseret på crcl.

forty-two percent of patients enrolled had both a crcl 6.
42% af patienterne havde både en crcl <70 ml/min og en co-morbiditetsscore over 6.

clinical monitoring is recommended for patients with crcl < 90 ml/min.
klinisk overvågning anbefales af patienter med crcl < 90 ml/min.

no dose adjustment is necessary in patients with mild or moderate renal impairment (crcl of
dosisjustering er ikke nødvendig hos patienter med let til moderat nedsat nyrefunktion (crcl

creatinine clearance (crcl) ml/min 30 crcl 80 ml/min.
kreatininclearance (crcl) ml/min.30 crcl 80 ml/min.

for patients with crcl < 60 ml/min, alternative antibacterials should be considered.
for patienter med crcl < 60 ml/min bør alternative antibakterielle midler overvejes.

there are no pharmacokinetic data on tenofovir alafenamide in patients with estimated crcl < 15 ml/min.
der foreligger ingen farmakokinetiske data om tenofoviralafenamid hos patienter med estimeret crcl < 15 ml/min.

creatinine clearance (crcl) must be determined for every cycle before the start of treatment on day 1.
creatinin-clearance (crcl) skal bestemmes for hvert behandlingsforløb ved starten af behandlingen på dag 1.

atripla is not recommended for patients with moderate or severe renal impairment (creatinine clearance (crcl) < 50 ml/ min).
atripla bør ikke gives til patienter med moderat eller svær nyreinsufficiens (kreatinin- clearance < 50 ml/ min).